137 related articles for article (PubMed ID: 34946930)
1. Genotype-Specific Lesion Growth Rates in Stargardt Disease.
Heath Jeffery RC; Thompson JA; Lo J; Lamey TM; McLaren TL; McAllister IL; Constable IJ; De Roach JN; Chen FK
Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946930
[TBL] [Abstract][Full Text] [Related]
2. Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9).
Strauss RW; Muñoz B; Ho A; Jha A; Michaelides M; Cideciyan AV; Audo I; Birch DG; Hariri AH; Nittala MG; Sadda S; West S; Scholl HPN;
JAMA Ophthalmol; 2017 Nov; 135(11):1232-1241. PubMed ID: 29049437
[TBL] [Abstract][Full Text] [Related]
3. ULTRAWIDEFIELD AUTOFLUORESENCE IN ABCA4 STARGARDT DISEASE.
Klufas MA; Tsui I; Sadda SR; Hosseini H; Schwartz SD
Retina; 2018 Feb; 38(2):403-415. PubMed ID: 28248825
[TBL] [Abstract][Full Text] [Related]
4. Incidence of Atrophic Lesions in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 5.
Strauss RW; Muñoz B; Ho A; Jha A; Michaelides M; Mohand-Said S; Cideciyan AV; Birch D; Hariri AH; Nittala MG; Sadda S; Scholl HPN;
JAMA Ophthalmol; 2017 Jul; 135(7):687-695. PubMed ID: 28542697
[TBL] [Abstract][Full Text] [Related]
5. CLASSIFYING ABCA4 MUTATION SEVERITY USING AGE-DEPENDENT ULTRA-WIDEFIELD FUNDUS AUTOFLUORESCENCE-DERIVED TOTAL LESION SIZE.
Heath Jeffery RC; Thompson JA; Lamey TM; McLaren TL; McAllister IL; Constable IJ; Mackey DA; De Roach JN; Chen FK
Retina; 2021 Dec; 41(12):2578-2588. PubMed ID: 34125082
[TBL] [Abstract][Full Text] [Related]
6. Clinical, Genotypic, and Imaging Characterization of the Spectrum of ABCA4 Retinopathies.
Romano F; Lamanna F; Boon CJF; Siligato A; Kalra G; Agarwal A; Medori C; Bertelli M; Pellegrini M; Invernizzi A; Staurenghi G; Salvetti AP
Ophthalmol Retina; 2024 May; 8(5):509-519. PubMed ID: 37924945
[TBL] [Abstract][Full Text] [Related]
7. Local progression kinetics of macular atrophy in recessive Stargardt disease.
Young BK; Zhao PY; Shen LL; Fahim AT; Jayasundera KT
Ophthalmic Genet; 2023 Dec; 44(6):539-546. PubMed ID: 37381907
[TBL] [Abstract][Full Text] [Related]
8. The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.
Strauss RW; Ho A; Muñoz B; Cideciyan AV; Sahel JA; Sunness JS; Birch DG; Bernstein PS; Michaelides M; Traboulsi EI; Zrenner E; Sadda S; Ervin AM; West S; Scholl HP;
Ophthalmology; 2016 Apr; 123(4):817-28. PubMed ID: 26786511
[TBL] [Abstract][Full Text] [Related]
9. Study of Late-Onset Stargardt Type 1 Disease: Characteristics, Genetics, and Progression.
Li CHZ; Pas JAAH; Corradi Z; Hitti-Malin RJ; Hoogstede A; Runhart EH; Dhooge PPA; Collin RWJ; Cremers FPM; Hoyng CB
Ophthalmology; 2024 Jan; 131(1):87-97. PubMed ID: 37598860
[TBL] [Abstract][Full Text] [Related]
10. Foveal sparing in Stargardt disease.
van Huet RA; Bax NM; Westeneng-Van Haaften SC; Muhamad M; Zonneveld-Vrieling MN; Hoefsloot LH; Cremers FP; Boon CJ; Klevering BJ; Hoyng CB
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7467-78. PubMed ID: 25324290
[TBL] [Abstract][Full Text] [Related]
11. Asymmetric Inter-Eye Progression in Stargardt Disease.
Lambertus S; Bax NM; Groenewoud JM; Cremers FP; van der Wilt GJ; Klevering BJ; Theelen T; Hoyng CB
Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6824-6830. PubMed ID: 28002570
[TBL] [Abstract][Full Text] [Related]
12. The absence of fundus abnormalities in Stargardt disease.
Bax NM; Lambertus S; Cremers FPM; Klevering BJ; Hoyng CB
Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1147-1157. PubMed ID: 30903310
[TBL] [Abstract][Full Text] [Related]
13. Atrophy Expansion Rates in Stargardt Disease Using Ultra-Widefield Fundus Autofluorescence.
Heath Jeffery RC; Thompson JA; Lo J; Lamey TM; McLaren TL; McAllister IL; Mackey DA; Constable IJ; De Roach JN; Chen FK
Ophthalmol Sci; 2021 Mar; 1(1):100005. PubMed ID: 36246008
[TBL] [Abstract][Full Text] [Related]
14. SIBLING CONCORDANCE IN SYMPTOM ONSET AND ATROPHY GROWTH RATES IN STARGARDT DISEASE USING ULTRA-WIDEFIELD FUNDUS AUTOFLUORESCENCE.
Heath Jeffery RC; Thompson JA; Lo J; Lamey TM; McLaren TL; De Roach JN; Azamanov DN; McAllister IL; Constable IJ; Chen FK
Retina; 2022 Aug; 42(8):1545-1559. PubMed ID: 35344533
[TBL] [Abstract][Full Text] [Related]
15. Early-onset stargardt disease: phenotypic and genotypic characteristics.
Lambertus S; van Huet RA; Bax NM; Hoefsloot LH; Cremers FP; Boon CJ; Klevering BJ; Hoyng CB
Ophthalmology; 2015 Feb; 122(2):335-44. PubMed ID: 25444351
[TBL] [Abstract][Full Text] [Related]
16. Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 24-Month Period (ProgStar Report No. 17).
Strauss RW; Ho A; Jha A; Fujinami K; Michaelides M; Cideciyan AV; Audo I; Birch DG; Sadda S; Ip M; West S; Schönbach EM; Kong X; Scholl HPN;
Am J Ophthalmol; 2023 Jun; 250():157-170. PubMed ID: 36764427
[TBL] [Abstract][Full Text] [Related]
17. A longitudinal study of Stargardt disease: quantitative assessment of fundus autofluorescence, progression, and genotype correlations.
Fujinami K; Lois N; Mukherjee R; McBain VA; Tsunoda K; Tsubota K; Stone EM; Fitzke FW; Bunce C; Moore AT; Webster AR; Michaelides M
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8181-90. PubMed ID: 24265018
[TBL] [Abstract][Full Text] [Related]
18. Clinical and genetic characteristics of late-onset Stargardt's disease.
Westeneng-van Haaften SC; Boon CJ; Cremers FP; Hoefsloot LH; den Hollander AI; Hoyng CB
Ophthalmology; 2012 Jun; 119(6):1199-210. PubMed ID: 22449572
[TBL] [Abstract][Full Text] [Related]
19. Progression of Late-Onset Stargardt Disease.
Lambertus S; Lindner M; Bax NM; Mauschitz MM; Nadal J; Schmid M; Schmitz-Valckenberg S; den Hollander AI; Weber BH; Holz FG; van der Wilt GJ; Fleckenstein M; Hoyng CB;
Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5186-5191. PubMed ID: 27699414
[TBL] [Abstract][Full Text] [Related]
20. Multimodal imaging and multifocal electroretinography demonstrate autosomal recessive Stargardt disease may present like occult macular dystrophy.
Sisk RA; Leng T
Retina; 2014 Aug; 34(8):1567-75. PubMed ID: 24743636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
